High prevalence and increasing incidence of Addison's disease in western Norway

被引:148
作者
Lovås, K [1 ]
Husebye, ES [1 ]
机构
[1] Haukeland Hosp, Inst Med, Div Endocrinol, N-5021 Bergen, Norway
关键词
D O I
10.1046/j.1365-2265.2002.t01-1-01552.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Estimates of the prevalence of Addison's disease in Caucasians have varied from 39 to 117 per million. We have carried out an epidemiological study to obtain a confident point prevalence estimate in the Norwegian population for the end of 1999, and to find out whether the incidence is changing. PATIENTS AND METHODS The patients were identified by a search through registers of 10 hospitals and consultant endocrinologists serving a population of 916 000. The completeness of the list was tested by a survey of general practitioners in one district, and by the member list of the local Addison Association in another district. RESULTS We identified 128 patients with Addison's disease (59 men and 69 women), yielding a prevalence of 140 per million. Recorded mean incidence in the past decade was 0.62 per 100 000 per year. Fifty-one patients (40%) had concomitant endocrine diseases. The aetiology was almost exclusively idiopathic or autoimmune. CONCLUSIONS We found a higher prevalence of Addison's disease in western Norway than has previously been reported anywhere. Our findings support the hypothesis of a rising incidence of autoimmune adrenal insufficiency.
引用
收藏
页码:787 / 791
页数:5
相关论文
共 19 条
  • [1] EFFECT OF GLUCOCORTICOID REPLACEMENT THERAPY ON GLUCOSE-TOLERANCE AND INTERMEDIARY METABOLITES IN HYPOPITUITARY ADULTS
    ALSHOUMER, KAS
    BESHYAH, SA
    NITHTHYANANTHAN, R
    JOHNSTON, DG
    [J]. CLINICAL ENDOCRINOLOGY, 1995, 42 (01) : 85 - 90
  • [2] Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: Markers of low progression to clinical Addison's disease .1.
    Betterle, C
    Volpato, M
    Smith, BR
    Furmaniak, J
    Chen, S
    Greggio, NA
    Sanzari, M
    Tedesco, F
    Pedini, B
    Boscaro, M
    Presotto, F
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (03) : 932 - 938
  • [3] Bone mineral density in patients with treated Addison's disease
    Braatvedt, GD
    Joyce, M
    Evans, M
    Clearwater, J
    Reid, IR
    [J]. OSTEOPOROSIS INTERNATIONAL, 1999, 10 (06) : 435 - 440
  • [4] DUNLOP D, 1963, BRIT MED J, P887
  • [5] Fletcher RH, 1996, CLIN EPIDEMIOLOGY ES, P84
  • [6] Guttman PH, 1930, ARCH PATHOL, V10, P742
  • [7] An assessment of optimal hydrocortisone replacement therapy
    Howlett, TA
    [J]. CLINICAL ENDOCRINOLOGY, 1997, 46 (03) : 263 - 268
  • [8] Assessment of corticosteroid replacement therapy in adults with adrenal insufficiency
    Jeffcoate, W
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 1999, 36 : 151 - 157
  • [9] 86 CASES OF ADDISONS-DISEASE
    KONG, MF
    JEFFCOATE, W
    [J]. CLINICAL ENDOCRINOLOGY, 1994, 41 (06) : 757 - 761
  • [10] Is the prevalence of Addison's disease underestimated?
    Laureti, S
    Vecchi, L
    Santeusanio, F
    Falorni, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (05) : 1762 - 1762